Technology

Organizations commonly navigate outdated systems that make collaboration harder and breakthroughs slower, causing delays, missed insights, and costly rework.

Webinar Date/Time: Thu, Aug 14, 2025 3:30 PM EDT

Gen Li discusses the current state of technological advancement in clinical trials.

Despite surging GenAI adoption in pharma and the FDA’s recent embrace of the technology, a trust gap remains with GenAI implementations. The story describes four essentials that improve trust in GenAI so that pharma and biotech teams can better navigate the present time of uncertainty.

New technology has the potential to improve trial design and patient recruitment.

A global survey of scientists and informaticians reveals growing AI investment across the biopharma value chain, but highlights gaps in data integration, standardization, and infrastructure that threaten to stall progress.

Neha Anand, Analyst, Biopharma Intelligence Services, Citeline, explains how the approval of Emrelis is accelerating investor interest, validating biomarker-driven ADCs, and shaping distinct strategic paths for pharma and biotech in the evolving precision oncology landscape.

With reports that FDA’s AI Elsa is “confidently hallucinating” studies that don’t exist, the use of AI to streamline drug review and speed up approval is not here yet.

The EVERSANA team discusses its new technology center that has a goal of pharmatizing AI.

Alliance Pharmaceuticals plans to use the new to attack counterfeiters rather than just defend against them.

Webinar Date/Time: Mon, Jul 28, 2025 11:00 AM EDT

It’s the caliber of leadership that brings teams together, demands accountability, and drives purposeful, decisive action.

The new platform integrates PCR-based diagnostic data with statistical modeling and AI to provide real-time visibility into infectious disease trends at local and global levels.

Biljana Naumovic, US President, oncology, solid tumor, Johnson & Johnson Innovative Medicine, discusses the importance of collaboration across the healthcare community to develop inclusive and effective AI solutions that enhance decision-making and patient outcomes in oncology.

The intersection of artificial intelligence and direct-to-consumer advertising presents unprecedented opportunities and evolving challenges as regulations and technologies reshape the biopharma landscape.

Prioritizing deeper customer insights helps life sciences marketers understand how to engage their HCP audiences effectively with the right message.

Research has shown a gap between the female patient experience compared to those of men.

The protection and privacy of healthcare data is a massive hurdle for the new technology to overcome.

Meeting the growing need and demand for fast information to make optimal and timely treatment decisions.

Navigating technology and regulatory shifts in pharma revenue management.

The provider hopes that this option will be a solution to the state’s primary care physician shortage.

Commissioner Markary announced the plans alongside the results of a generative AI pilot for scientific reviewers.

The pharma tech company announced a deal with Starvision to roll out its services across the network over the next five years.

Blake Powers, CEO, medigi, explains how digital tools, AI, and automation are streamlining access to biosimilars and cell and gene therapies, signaling a shift toward more tech-enabled, patient-centric care.

Capan discusses the collaboration between AWS and EVERSANA in the first part of this two-part interview.